Mustang Bio, Inc. (MBIO) stock
MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.35−0.02 (-4.30%)
Close on Nov 20, 2026Market cap $2.68MP/E –Yield –
Mustang Bio free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Mustang Bio's free cash flow for the twelve months ending Dec 31, 2024 was -$11.41M. For fiscal 2024 it was -$11.41M. The highest annual figure on record is -$11.41M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$11.41M | – |
| FY2023 | Dec 31, 2023 | -$49.54M | – |
| FY2022 | Dec 31, 2022 | -$67.78M | – |
| FY2021 | Dec 31, 2021 | -$57.65M | – |
| FY2020 | Dec 31, 2020 | -$39.24M | – |
| FY2019 | Dec 31, 2019 | -$35.93M | – |
| FY2018 | Dec 31, 2018 | -$26.11M | – |
| FY2017 | Dec 31, 2017 | -$13.37M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$2.00M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.76M | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.28M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.02M | – |
| Q2 FY2023 | Jun 30, 2023 | -$12.43M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.81M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$16.89M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.88M | – |
| Q1 FY2022 | Mar 31, 2022 | -$17.62M | – |
| Q4 FY2021 | Dec 31, 2021 | -$16.08M | – |
| Q3 FY2021 | Sep 30, 2021 | -$11.75M | – |
| Q2 FY2021 | Jun 30, 2021 | -$13.79M | – |
| Q1 FY2021 | Mar 31, 2021 | -$16.04M | – |
| Q4 FY2020 | Dec 31, 2020 | -$10.17M | – |
| Q3 FY2020 | Sep 30, 2020 | -$10.26M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.13M | – |
| Q1 FY2020 | Mar 31, 2020 | -$10.68M | – |
| Q4 FY2019 | Dec 31, 2019 | -$10.38M | – |
| Q3 FY2019 | Sep 30, 2019 | -$9.33M | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.43M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.78M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.83M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.95M | – |
| Q2 FY2018 | Jun 30, 2018 | -$8.10M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.24M | – |
| Q4 FY2017 | Dec 31, 2017 | -$5.57M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.79M | – |
See a number that looks wrong?